Elliptic Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Elliptic Laboratories has a total shareholder equity of NOK307.1M and total debt of NOK6.0M, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are NOK349.9M and NOK42.8M respectively.
Key information
2.0%
Debt to equity ratio
kr6.00m
Debt
Interest coverage ratio | n/a |
Cash | kr115.58m |
Equity | kr307.11m |
Total liabilities | kr42.80m |
Total assets | kr349.91m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ELABS's short term assets (NOK185.6M) exceed its short term liabilities (NOK24.9M).
Long Term Liabilities: ELABS's short term assets (NOK185.6M) exceed its long term liabilities (NOK17.9M).
Debt to Equity History and Analysis
Debt Level: ELABS has more cash than its total debt.
Reducing Debt: ELABS's debt to equity ratio has reduced from 90.7% to 2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ELABS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ELABS has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 14.2% each year.